Oculogica specializes in the fields of neuro-diagnostics, brain injury, TBI, concussion, and eye tracking.
Oculogica has raised $7.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2024.
Oculogica's investors include TitletownTech, Golden Seeds, Sofia Fund, Colle Capital Partners, Daren Cotter.
Oculogica is headquartered in New York, United States.
Oculogica specializes in the fields of neuro-diagnostics, brain injury, TBI, concussion, and eye tracking.
Oculogica is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oculogica — Funding & Investors." VCBacked, May 13, 2024, https://www.vcbacked.co/company/oculogica. Accessed November 13, 2026.
VCBacked. (2024). Oculogica — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/oculogica
{{cite web |title=Oculogica — Funding & Investors |url=https://www.vcbacked.co/company/oculogica |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Oculogica? Request a listing update